Fresenius Medical Care upgraded to "buy"

22.04.09 - UniCredit Markets & Investment Banking

LONDON, April 22 (newratings.com) - Analysts at UniCredit Markets upgrade Fresenius Medical Care (FME) from "hold" to "buy." The target price is set to ?45.

In a research note published this morning, the analysts mention that the recent decline in the company?s share price and its strong defensive qualities make it an attractive pick. The analysts expect Fresenius Medical Care to post robust 2009 results, with sales increasing by 18% and EBIT rising by 47%. Market fears related to the new health care reform and its impact on the company are overdone, UniCredit Markets says.